Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPFONSECA, Leonardo G.CHEN, Andre T. C.OLIVEIRA, Irai S. deCHAGAS, Aline L.KRUGER, Jaime A. P.CARRILHO, Flair J.2024-04-052024-04-052023JCO GLOBAL ONCOLOGY, v.9, article ID e2200416, 10p, 2023https://observatorio.fm.usp.br/handle/OPI/58882The incidence of hepatocellular carcinoma (HCC) is expected to increase in the coming years, and strategies to mitigate the burden of this disease are needed in different regions. Geographic variations in epidemiology and risk factors, such as viral hepatitis and metabolic disease, pose challenges in adopting programs for early detection programs and management of patients with HCC. Brazil, like other countries, has high economic and social inequality, with heterogeneous access to health care. Viral hepatitis is themain risk factor but there is growing awareness of fatty liver disease. Risk factor monitoring and screening programs are unmet priorities because patients are often diagnosed at later stages. Advances in the management of patients with HCC have been made in recent years, including new tools for selecting patients for liver transplantation, sophisticated surgical techniques, and new systemic agents. High-volume academic centers often achieve favorable results through the adoption and application of established treatments, but this is not a reality in most regions of Brazil, because of disparities in wealth and resources. As HCC management requires a coordinated and multidisciplinary team, the role of local referral centers in decentralizing access to treatments and promoting health education in different regions should be encouraged and supported.engopenAccesspercutaneous radiofrequency ablationstereotactic body radiotherapyrandomized controlled-trialacetic-acid injectionphase-iiiethanol injectionliver-transplantationsurgical resectionpartial-hepatectomymicrowave ablationarticleCopyright LIPPINCOTT WILLIAMS & WILKINS10.1200/GO.22.00416Oncology2687-8941